{"title":"Design and Expression of Recombinant cell Penetrating Protein Based on Tat and pertussis-like Toxin A and Evaluation of its Effects on the lung cancer","authors":"Arman Mahdavi, Hamideh Mahmoodzadeh Hosseini, Reza Ranjbar, Jafar Amani, Soghra Khani, Seyed Ali Mirhosseini","doi":"10.1007/s10989-024-10611-z","DOIUrl":null,"url":null,"abstract":"<p>Nowadays, design of cytotoxic agents based on microbial toxins is attracted for researchers. Pertussis-like toxin subunit A (PltA) of typhoid toxin is ADP-ribosyl transferase and had the cytotoxicity and cell arrest property in G2/M phase of human cancer cell line. To translocate and its increase to the cells, PltA requires the cell penetrating part. Here, the catalytic PltA (named Typh) was attached to Tat peptide as a cell penetrating agent and expressed as a new recombinant fusion protein (named Tat-Typh) in <i>E. coli</i> BL21. After that, recombinant Tat-Typh was purified using Ni + chromatography column and confirmed by western blotting. Finally, its cytotoxicity effects and cell penetration activity were evaluated by, MTT assay, Annexin-V/PI staining and western blotting methods, respectively. Our results showed that Tat-Typh had the significant cytotoxic effect at 25, 50, 150 and 200 µg/mL concentrations (<i>P</i> < 0.05). In addition, cell treating with 50 µg/mL Tat-Typh was resulted in to increase the percentage of necrotic cells compared to control groups (<i>P</i> < 0.05). Moreover, binding of Tat fragment to Typh protein caused to increase the speed of entry of Tat-Typh to cells compared to Typh alone. In conclusion, it is observed that Tat-Typh protein is able to increase the cell penetration properties of catalytic Pertussis-like toxin subunit A and has the cytotoxic effects on lung cancer cell line.</p>","PeriodicalId":14217,"journal":{"name":"International Journal of Peptide Research and Therapeutics","volume":"36 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Peptide Research and Therapeutics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10989-024-10611-z","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Nowadays, design of cytotoxic agents based on microbial toxins is attracted for researchers. Pertussis-like toxin subunit A (PltA) of typhoid toxin is ADP-ribosyl transferase and had the cytotoxicity and cell arrest property in G2/M phase of human cancer cell line. To translocate and its increase to the cells, PltA requires the cell penetrating part. Here, the catalytic PltA (named Typh) was attached to Tat peptide as a cell penetrating agent and expressed as a new recombinant fusion protein (named Tat-Typh) in E. coli BL21. After that, recombinant Tat-Typh was purified using Ni + chromatography column and confirmed by western blotting. Finally, its cytotoxicity effects and cell penetration activity were evaluated by, MTT assay, Annexin-V/PI staining and western blotting methods, respectively. Our results showed that Tat-Typh had the significant cytotoxic effect at 25, 50, 150 and 200 µg/mL concentrations (P < 0.05). In addition, cell treating with 50 µg/mL Tat-Typh was resulted in to increase the percentage of necrotic cells compared to control groups (P < 0.05). Moreover, binding of Tat fragment to Typh protein caused to increase the speed of entry of Tat-Typh to cells compared to Typh alone. In conclusion, it is observed that Tat-Typh protein is able to increase the cell penetration properties of catalytic Pertussis-like toxin subunit A and has the cytotoxic effects on lung cancer cell line.
期刊介绍:
The International Journal for Peptide Research & Therapeutics is an international, peer-reviewed journal focusing on issues, research, and integration of knowledge on the latest developments in peptide therapeutics. The Journal brings together in a single source the most exciting work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives. The Journal invites substantial contributions in the following thematic areas:
-New advances in peptide drug delivery systems.
-Application of peptide therapeutics to specific diseases.
-New advances in synthetic methods.
-The development of new procedures for construction of peptide libraries and methodology for screening of such mixtures.
-The use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions
-Applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.